[Featured Stock] HL Biopharma and HL Biopharma Saenggwa Surge on No-Additional-Share Announcement
[Asia Economy Reporter Ji Yeon-jin] HL Biotech surged on the 26th following news of a free share issuance.
As of 9:45 AM on the same day, HL Biotech was trading at 72,100 KRW, up 14.58% (9,000 KRW) compared to the previous day. At the same time, HL Biotech Life Science was trading at 17,950 KRW, up 15.11% from the previous day.
On this day, HL Biotech and HL Biotech Life Science announced a 100% free share issuance. Existing shareholders will receive one free share for each share they hold.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- Brilliant Korean Technology Flows Overseas... Subsidies Granted, but "No Product Launch Allowed"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- Singer Kim Minjong Responds to MC Mong's Gambling Allegations: "Clearly False... Legal Action to Follow"
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
HL Biotech's stock price had plummeted after reports that it was under investigation by financial authorities over allegations of false disclosure, with malicious rumors such as trading suspension spreading, but it rebounded starting from the 19th. This came after news that its subsidiary, HL Biotech Pharmaceutical, had completed all late-stage clinical trials of rivoceranib for advanced gastric cancer and is preparing a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA). As of 9:49 AM on the same day, HL Biotech Pharmaceutical was trading at 16,100 KRW, up 4.55% from the previous day.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Cheaper Than Candy, Yet Impossible to Find... Fears of a 'Pediatric Medical Crisis' as Pharmaceutical Companies Halt Production [Why&Next]](https://cwcontent.asiae.co.kr/asiaresize/307/2026051910065268365_1779152813.jpg)
